Matinas BioPharma Holdings, Inc. (MTNB)
About Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2023
- $1.1M
- Net income
- -$10.3M
- Total assets
- $7.2M
- Market cap
- $5.1M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating income
- -$7.0M
- Income tax
- $7.0K
- Net income
- -$10.3M
- EPS (basic)
- $-2.00
- EPS (diluted)
- $-2.00
Balance sheet
- Total assets
- $7.2M
- Current assets
- $4.1M
- Total liabilities
- $2.4M
- Current liabilities
- $1.5M
- Shareholders’ equity
- $4.8M
Cash flow
- Operating cash flow
- -$7.0M
- Investing cash flow
- $335.0K
- Financing cash flow
- $3.4M
- Net cash flow
- -$3.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $5.1M
- EPS (diluted)
- $-2.0
- Shares outstanding
- 21.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 21, 2014
Matinas BioPharma Holdings, Inc. (MTNB) Stock Price
- Reported a net loss of $10.3M in FY2023.
- Trading 90% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Matinas BioPharma Holdings, Inc..
Write a review
News about Matinas BioPharma Holdings, Inc.
News & sentiment via Polygon.io
Matinas BioPharma Holdings, Inc.: frequently asked questions
Is Matinas BioPharma Holdings, Inc. an American company?
Matinas BioPharma Holdings, Inc. is a US-based company headquartered in Bedminster, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Matinas BioPharma Holdings, Inc. headquartered?
Matinas BioPharma Holdings, Inc. is headquartered in Bedminster, New Jersey, United States.
Is Matinas BioPharma Holdings, Inc. publicly traded?
Yes — Matinas BioPharma Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol MTNB on the NYSE.
What does Matinas BioPharma Holdings, Inc. do?
Matinas BioPharma Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
